The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Otrivin, Balminil Decongest
Synonyms :
oxymetazoline (nasal)
Class :
Drugs for asthma and COPD & Decongestant (Alpha-Adrenergic Agonist)
Dosage forms & Strengths:Â
Intranasal solutionÂ
0.05%Â
Dosage forms & Strengths:Â
Intranasal solutionÂ
0.05%Â
0.025%Â
Refer adult dosingÂ
may increase the hypertension effect
methacholine: they may increase the hypertensive effect of sympathomimetics
it increases the toxicity of sympathomimetics
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the hypertension effect
aclidinium: they may increase the hypertensive effect of sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may enhance the tachycardic effect
may enhance the tachycardic effect
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
sympathomimetics increase the effect of hypertension of solriamfetol
it increases the effect of hypertension of sympathomimetics
it increases the arrhythmogenic effect of sympathomimetics
sympathomimetics increase the toxicity of doxofylline
it increases the effect of hypertension of sympathomimetics
may increase the hypertension effect
may increase the therapeutic effect
may enhance the adverse/toxic effect of sympathomimetics
may increase the tachycardic effect of cannabinoid-containing products
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may have an increased tachycardic effect when combined with sympathomimetics
may have an increased tachycardic effect when combined with sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
oxymetazoline and safinamide increase the sympathetic effects
may increase the adverse effect of each other when combined
may enhance the risk of adverse effects
may enhance the risk of adverse effects
may enhance the risk of adverse effects
may enhance the risk of adverse effects
May increase the adverse effect when combined
may enhance the serum concentration when combined
esketamine: they may increase the arrhythmogenic effect of sympathomimetics
pergolide: they may increase the hypertensive effect of sympathomimetics
piribedil: they may increase the hypertensive effect of sympathomimetics
trimeprazine: they may increase the hypertensive effect of sympathomimetics
valerian: they may increase the hypertensive effect of sympathomimetics
secretin: they may increase the hypertensive effect of sympathomimetics
aldesleukin: they may increase the hypertensive effect of sympathomimetics
cimetropium: they may increase the hypertensive effect of sympathomimetics
desmopressin: they may increase the hypertensive effect of sympathomimetics
eluxadoline: they may increase the hypertensive effect of sympathomimetics
levosulpiride: they may increase the hypertensive effect of sympathomimetics
oxatomide: they may increase the hypertensive effect of sympathomimetics
revefenacin: they may increase the hypertensive effect of sympathomimetics
tiotropium: they may increase the hypertensive effect of sympathomimetics
amantadine: they may increase the hypertensive effect of sympathomimetics
mometasone furoate: they may increase the hypertensive effect of sympathomimetics
itopride: they may increase the hypertensive effect of sympathomimetics
mirabegron: they may increase the hypertensive effect of sympathomimetics
nitroglycerin: they may increase the hypertensive effect of sympathomimetics
tobacco: they may increase the hypertensive effect of sympathomimetics
topiramate: they may increase the hypertensive effect of sympathomimetics
theophylline: they may increase the hypertensive effect of sympathomimetics
cosyntropin: they may increase the hypertensive effect of sympathomimetics
dapsone: they may increase the hypertensive effect of sympathomimetics
it increases the effect of hypertension of sympathomimetics
it increases the effect of hypertension of sympathomimetics
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
The Gq and Gi-protein-coupled α1- and α2-adrenoceptors are the receptors that oxymetazoline binds to. Phospholipase C is activated by α1-adrenoceptor agonism, which raises intracellular calcium levels and encourages vascular smooth muscle contraction.Â
It is thought that oxymetazoline reduces erythema symptoms by producing vasoconstriction and activating α1A-adrenoceptors.Â
In dentistry, oxymetazoline and tetracaine are combined to provide local anesthetic. The use of this combination has additional positive effects: the vasoconstrictor reduces blood flow to the application region by restricting dilated arterioles and counteracting the vasodilatory activity of the local anesthetic agent.Â
Frequency defined:Â Â Â
>10%Â
Headache Â
1% to 10%Â
DizzinessÂ
NauseaÂ
PainÂ
Back painÂ
MyalgiaÂ
WeaknessÂ
Fever Â
<1%Â
EdemaÂ
ArthralgiaÂ
BruiseÂ
HepatitisÂ
Hepatic failureÂ
Insomnia  Â
Â
None
Contraindication:Â
HypersensitivityÂ
Caution:Â
Hypertension or heart diseaseÂ
Diabetes mellitusÂ
Thyroid diseaseÂ
Prostatic hyperplasiaÂ
Pregnancy consideration: Limited Not recommended to be administered during pregnancy.Â
Lactation: Oxymetazoline excretion in breast milk is not known. Â
Pregnancy category:Â
Â
Oxymetazoline is a direct-acting sympathomimetic and an adrenergic α1- and α2-agonist. Oxymetazoline produces vasoconstriction of dilated arterioles and decreases blood flow by activating adrenergic receptors.Â
Oxymetazoline showed greater potency at α2B-adrenoceptors but a greater affinity at α1A-adrenoceptors than α2B-adrenoceptors.Â
Oximetazoline has antioxidant properties in early in vitro research, where it mediated hydroxyl radical scavenging activity and prevented microsomal lipid peroxidation.Â
For nose drops:Â
Gently blow your nose. You can either lie down and hang your head over the side of a bed or tilt your head back as far as you can. Place the appropriate number of drops into your nose while holding the dropper over it.Â
Patient should lean their head forward a little and then slowly rotate it to the left and right. For several minutes, remain seated with your head bowed.Â
For nasal spray:Â
Give your nose a little blow. Place the bottle’s tip into one nostril while maintaining an upright posture. Using your finger, close the other nostril. Inhale rapidly and lightly mist your nose with the medication.Â
After applying the nasal spray, wait at least a few minutes before blowing your nose.Â
The nasal spray should not be used more than twice in a 24-hour period.Â
Patient information leafletÂ
Generic Name: oxymetazoline (nasal)Â
Why do we use oxymetazoline (nasal)? Â
The nasal passages’ blood vessels constrict when oxymetazoline is used as a decongestant. A stuffy nose or congestion of the nose can be caused by dilated blood vessels.Â
A typical cold or allergy-related nasal congestion can be temporarily relieved with oxymetazoline nasal (for the nose).Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
